Conavi Medical (TSE:CNVI) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Conavi Medical’s Novasight Hybrid System, which uniquely combines IVUS and OCT for comprehensive coronary artery imaging, has been highlighted in a peer-reviewed article for its potential to improve cardiovascular procedures. This innovative technology is currently being showcased at the TCT 2024 conference, emphasizing its promising future in enhancing patient care.
For further insights into TSE:CNVI stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue